Navigation Links
Amgen’s Fourth Quarter 2010 Adjusted Earnings Per Share Increased 11 Percent to $1.17; Full Year 2010 Adjusted Earnings Per Share Increased 6 Percent to $5.21
Date:1/24/2011

the adjustments between our GAAP and “Adjusted” results takes into account the tax treatment and related tax rate(s) that apply to each adjustment in the applicable tax jurisdiction(s).  Generally, this results in a tax impact at the U.S. marginal tax rate for certain adjustments, including amortization of intangible assets and non-cash interest expense associated with our convertible notes, whereas the tax impact of other adjustments, including impairments, stock option expense and restructuring-related items, depends on whether the amounts are deductible in the tax jurisdictions where the asset is located or the expenses are incurred and the applicable tax rate(s) in those jurisdictions.  Due to these factors, the effective tax rates for the above adjustments to our GAAP results for the three and twelve months ended December 31, 2010 and 2009 were 35.0% and 36.5% and 30.2% and 35.2%, respectively.(i)To exclude the net income tax benefit recognized as a result of resolving certain non-routine transfer pricing issues with tax authorities for prior periods.(j)To exclude the income tax benefit principally related to certain prior period charges excluded from "Adjusted" earnings.(k)To exclude the net income tax benefit resulting from adjustments to previously established deferred taxes, primarily related to prior acquisitions and stock option expense, due to changes in California tax law effective in 2011.(l)The following table presents the computations for GAAP and "Adjusted" diluted earnings per share, computed under the treasury stock method. "Adjusted" earnings per share presented below excludes stock option expense:Three months endedThree months endedDecember 31, 2010December 31, 2009GAAP"Adjusted"  GAAP"Adjusted" Income (Numerator):Net income for basic and diluted EPS$
,022$
,103$
931$
,065Shares (Denominator):Weighted-average shares for basic EPS9409401,0061,006Effect of dilutive securities66

(*)56

'/>"/>

SOURCE Amgen
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18

Related medicine technology :

1. Amgen’s Third Quarter 2010 Revenue Unchanged at $3.8 Billion Versus Prior Year
2. Neurocrine Biosciences Reports Fourth Quarter and Year-End 2007 Results
3. Sangamo BioSciences Reports 2007 Fourth Quarter and Year-End Financial Results
4. PLC Systems Reports Fourth Quarter 2007 Results
5. Memory Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Financial Results
6. Genta Incorporated Announces Fourth Quarter and Year End 2007 Financial Results and Corporate Highlights
7. GeoVax Labs, Inc. Reports Fourth Quarter and Year-End 2007 Financial Results
8. Novavax Reports Fourth Quarter and 2007 Year-End Financial Results
9. Catalyst Pharmaceutical Partners Reports Fourth Quarter and Year-End 2007 Financial Results
10. Halozyme Therapeutics Announces Roche Begins Phase 1 Clinical Trial and Selects Fourth Exclusive Biologic Target
11. Human Genome Sciences Announces Fourth-Quarter and Full-Year 2008 Financial Results and Key Developments
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2015)... Intarcia Therapeutics, Inc. today announced ... recently announced synthetic royalty / equity convert financing, bringing ... purchased Convertible Limited Recourse Notes from Intarcia and are ... any future global net sales of ITCA 650 until ... have the option, commencing upon U.S. regulatory approval of ...
(Date:6/2/2015)... -- ANI Pharmaceuticals, Inc. ("ANI") (NASDAQ: ANIP ) ... U.S. Food and Drug Administration (FDA) of its Abbreviated ... 5mg/5mL. Trailing twelve-month sales for the product are $30 ... expects to begin shipping to its customers shortly. ... of ANI Pharmaceuticals, stated, "This ANDA represents ANI,s first ...
(Date:6/2/2015)... 2, 2015  PROMETRIKA, LLC, a full-service clinical ... the addition of pharmacovigilance services for clinical trials.  ... safety data collection and reporting, as our service ... and expert physicians, each with more than 23 years ... monitoring of safety trends. ...
Breaking Medicine Technology:Intarcia Exercises Re-Opener For Its Recently Closed Royalty / Equity Convert Financing - Raising Total To $300 Million 2Intarcia Exercises Re-Opener For Its Recently Closed Royalty / Equity Convert Financing - Raising Total To $300 Million 3ANI Pharmaceuticals Announces FDA Approval of Oxycodone Hydrochloride Oral Solution 5mg/5mL 2ANI Pharmaceuticals Announces FDA Approval of Oxycodone Hydrochloride Oral Solution 5mg/5mL 3PROMETRIKA Announces the Availability of Pharmacovigilance Services 2
... SAN DIEGO, July 9 Arena Pharmaceuticals, ... results from a multiple-ascending,dose Phase 1b clinical ... safety,pharmacokinetics and pharmacodynamics. APD791 is Arena,s internally,discovered ... of arterial,thrombosis and other related conditions., ...
... July 8 After meeting on July 1st ... new diabetes drugs should,undergo trials to rule out ... US endocrinologists agree with this recommendation, according to,AlphaDetail ... market,research and key opinion leader mapping solutions to ...
Cached Medicine Technology:Arena Pharmaceuticals Announces Positive Phase 1b Clinical Trial Results of APD791 for the Treatment of Arterial Thrombosis 2Arena Pharmaceuticals Announces Positive Phase 1b Clinical Trial Results of APD791 for the Treatment of Arterial Thrombosis 3Arena Pharmaceuticals Announces Positive Phase 1b Clinical Trial Results of APD791 for the Treatment of Arterial Thrombosis 4Arena Pharmaceuticals Announces Positive Phase 1b Clinical Trial Results of APD791 for the Treatment of Arterial Thrombosis 5AlphaDetail AlphaPulse(TM): Most Practicing Physicians React Positively to FDA Panel's Recommendation for Additional Cardiovascular Safety Trials for New Diabetes Medications. 2
(Date:6/2/2015)... Allred Dental, a dental office based in San Marcos ... along with a $100 off with free oral sedation special ... wisdom teeth can be impacted, meaning that they are enclosed ... partially break through the gum, causing pain and inflammation of ... people, as they do not have fully developed wisdom teeth ...
(Date:6/2/2015)... CA (PRWEB) June 02, 2015 ... system was released to public yesterday, and has ... Internet. HonestyFirstReviews.com's senior product reviewer Tiffany Hendricks has ... detailed review of the course on her website ... courses available for Internet marketers looking to hone ...
(Date:6/2/2015)... 02, 2015 On March 19th, 2015, ... in the Hall of Legends at Detroit’s Ford Field. ... speaker Herman Moore, the goal of the conference was ... today’s society, highlight the benefits of effective professional rehabilitation ... about the options that are available to them in ...
(Date:6/2/2015)... Milwaukee, WI (PRWEB) June 02, 2015 ... to announce Lauren Potter from the hit show Glee ... Down Syndrome Awareness Walk in Pleasant Prairie, WI. The ... services for families in Racine, Kenosha, and Walworth counties. ... to have Lauren join us for this important event," ...
(Date:6/2/2015)... June 02, 2015 The Horizon Blue ... today that its Walking and Wellness Challenge, held this ... Acer, has raised another $3,000 for the Boys & ... the challenge, recording 32,000 steps on her fitbit during ... Hotel & Golf Club in Galloway Township. , ...
Breaking Medicine News(10 mins):Health News:$100 Off Coupon for Wisdom Teeth Extractions Offered at Allred Dental 2Health News:100K Factory - Review of Aidan Booth and Steve Clayton's New IM System Published 2Health News:Rehabilitation Facility Graduate Shares Her Story at "Fighting Addiction Together" Conference 2Health News:Glee star Lauren Potter helps Down Syndrome Association of WI raise awareness, support 2Health News:LPGA’s Natalie Gulbis Raises an Additional $3,000 for the Boys & Girls Club of Atlantic City Through Horizon BCBSNJ’s Walking and Wellness Challenge 2
... LOS ANGELES, Dec. 15 The holidays will be ... Southern California,s,largest children,s hospitals thanks to supermarket partners Ralphs ... The two supermarket chains announced today that they ... in communities served by their,stores in Southern California. The ...
... Dec. 15 The American Academy of,Dermatology (Academy) today issued ... to Congress about labeling information on the,relationship between the use ... skin damage. The FDA report was submitted pursuant to ... 2007. , "The American ...
... under age 65 were without health insurance for all or ... by the UCLA Center for Health Policy Research. ... California Health Interview Survey (CHIS), the policy brief,s authors found ... all or some of 2007, the most recent year for ...
... Aurora Health Care announced today that,the physicians of ... Wisconsin, have chosen to join Aurora Medical Group. , ... practice chiefly at Aurora hospitals and,clinics. , ... contribute to the quality,of the care we provide for Aurora ...
... from Medarex,s UltiMAb(R) technology platform - , ... (Nasdaq: MEDX ) today announced that it will ... in connection with the recently announced marketing approval from Health ... (ustekinumab, previously known as CNTO 1275) for ...
... lead people to choose salads over French fries? According to ... , people who choose from a large variety of menu ... who choose from shorter lists. , In a study that ... authors Aner Sela (Stanford University), Jonah Berger (University of Pennsylvania), ...
Cached Medicine News:Health News:Southern California Children's Hospitals to Receive $125,000 Holiday Gift From Ralphs and Food 4 Less 2Health News:American Academy of Dermatology Issues Statement on FDA Report to Congress About Labeling Information on Indoor Tanning Devices 2Health News:Nearly 6.4 million Californians lack health insurance, report shows 2Health News:Great Lakes Radiologists to Join Aurora Medical Group 2Health News:Medarex to Receive Milestone Payment for Approval of STELARA(TM) (Ustekinumab) for the Treatment of Moderate to Severe Plaque Psoriasis 2Health News:Medarex to Receive Milestone Payment for Approval of STELARA(TM) (Ustekinumab) for the Treatment of Moderate to Severe Plaque Psoriasis 3Health News:The virtue of variety: More options can lead to healthier choices 2
... a low-price PC-based, 2-8-channel system for ... the retina and the optic nerve. ... operator monitor, printer, keyboard, mouse, bioelectrical ... electrical connections are easily to install. ...
... tool that allows to see the fundus ... stimulated. Besides it also includes the refractive ... between the pupil picture and the fundus ... is especially suited for animal research and ...
5 mm...
Cannula and irrigation extension. Overall Length 150 mm (6.25"). Light Curve....
Medicine Products: